AVAI BIO, INC. (AVAI) Operating income 2019–2026
AVAI BIO, INC. (AVAI) annual operating income history from SEC filings — each fiscal year as reported.
-$1.7MFY2026 · since FY2019: -$78,225 → -$1.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$1.7M | -53.2% |
| FY2025 | -$1.1M | +46.3% |
| FY2024 | -$2.1M | -510.0% |
| FY2023 | -$348,933 | -375.8% |
| FY2022 | $126,521 | -58.1% |
| FY2021 | $302,292 | +334.4% |
| FY2020 | $69,593 | +189.0% |
| FY2019 | -$78,225 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AVAI financial trends
AVAI RevenueAVAI Net incomeAVAI Net marginAVAI Gross profitAVAI Gross marginAVAI Operating marginAVAI Operating cash flowAVAI Free cash flowAVAI Capital expendituresAVAI Return on equityAVAI Stock buybacksAVAI Dividends paidAVAI Total assetsAVAI Total liabilitiesAVAI Shareholders’ equityAVAI overview →